Skip to menu Skip to content Skip to footer
Professor Paul Griffin
Professor

Paul Griffin

Email: 

Overview

Background

Associate Professor Paul Griffin is the Director of Infectious Diseases at Mater Health Services in Brisbane and Associate Professor of Medicine at the University of Queensland Medical School. He has fellowships in Infectious Diseases from the Royal Australasian College of Physicians, in Clinical Microbiology from the Royal College of Pathologists of Australasia and from the Australasian College of Tropical Medicine.

Paul is the Principal Investigator and Medical Director at Nucleus Network, a specialized contract research organisation specializing in early and late phase trials in infectious diseases where he has been the principal investigator on in excess of 125 clinical trials, predominantly in Infectious Diseases including novel vaccines and Malaria human challenge studies. This includes 8 vaccines for COVID-19 and a number of COVID-19 therapies.

As a Clinical Microbiologist, he maintains an active interest in diagnostic microbiology with a focus on clinical applications of faecal microbiome metagenomic sequencing.

In addition to a teaching role at the University of Queensland, Paul is also the chair of the Advanced Training Committee in Infectious Diseases with the Royal Australasian College of Physicians, the committee that oversees the training of Infectious Diseases specialists in Australia.

Finally, as a director and scientific advisory board member of the immunisation coalition, Paul has an active interest in vaccine education and advocacy and has become a trusted media authority and spokesperson across the nation during the COVID-19 pandemic.

Availability

Professor Paul Griffin is:
Available for supervision
Media expert

Research impacts

While performing vital clinical and research duties, he has also devoted time to inform, educate and reassure the community via a wide range of media appearances. He has featured regularly on prominent Australian programs across television, radio, print and online including The Project, Sunrise, Today Show, A Current Affair, and internationally including Canada’s CTV and the BBC.

Works

Search Professor Paul Griffin’s works on UQ eSpace

90 works between 2005 and 2024

81 - 90 of 90 works

2013

Conference Publication

Rapid identification of VRE with MALDI-TOF MS

Griffin, Paul M., Price, Gareth R., Schooneveldt, Jacqueline M., Schlebusch, Sanmarié, Urbanski, Tess, Hamilton, Brett and Venter, Deon (2013). Rapid identification of VRE with MALDI-TOF MS. Australasian Division of the International Academy of Pathology 37th Annual Scientific Meeting 2012, Sydney, NSW Australia, 1-3 June 2012. London, United Kingdom: Elsevier. doi: 10.1097/01.pat.0000426852.32930.4a

Rapid identification of VRE with MALDI-TOF MS

2012

Journal Article

Chronic urticaria following acute hepatitis A

Griffin, Paul M., Kevat, Dev A. S., McCarthy, James S. and Woods, Marion L. (2012). Chronic urticaria following acute hepatitis A. BMJ case reports, 2012 (sep18 1), bcr2012006479-bcr2012006479. doi: 10.1136/bcr-2012-006479

Chronic urticaria following acute hepatitis A

2012

Journal Article

Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry to identify vancomycin-resistant enterococci and investigate the epidemiology of an outbreak

Griffin, Paul M., Price, Gareth R., Schooneveldt, Jacqueline M., Schlebusch, Sanmarie, Tilse, Martyn H., Urbanski, Tess, Hamilton, Brett and Venter, Deon (2012). Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry to identify vancomycin-resistant enterococci and investigate the epidemiology of an outbreak. Journal of Clinical Microbiology, 50 (9), 2918-2931. doi: 10.1128/JCM.01000-12

Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry to identify vancomycin-resistant enterococci and investigate the epidemiology of an outbreak

2011

Journal Article

A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs

McCarthy, James S., Sekuloski, Silvana, Griffin, Paul M., Elliott, Suzanne, Douglas, Nanette, Peatey, Chris, Rockett, Rebecca, O'Rourke, Peter, Marquart, Louise, Hermsen, Cornelius, Duparc, Stephan, Moehrle, Joerg, Trenholme, Katharine R. and Humberstone, Andrew J. (2011). A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs. PLoS ONE, 6 (8) e21914, e21914-1-e21914-8. doi: 10.1371/journal.pone.0021914

A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs

2010

Journal Article

Malaria: Part 2

Griffin, Paul and McCarthy, James (2010). Malaria: Part 2. Medical Observer, 23-23.

Malaria: Part 2

2010

Journal Article

Malaria: Part 1

Griffin, Paul and McCarthy, James (2010). Malaria: Part 1. Medical Observer, 23-23.

Malaria: Part 1

2010

Book Chapter

Diloxanide furoate

Griffin, Paul M. (2010). Diloxanide furoate. Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic and Antiviral Drugs. (pp. 2121-2124) edited by M. Lindsay Grayson, Suzanne M. Crowe, James S. McCarthy, John Mills, Johan W. Mouton, S. Ragnar Norrby, David L. Paterson and Michael A. Pfaller. Boca Raton, FL, USA: CRC Press. doi: 10.1201/b13787-206

Diloxanide furoate

2010

Book Chapter

Niclosamide

Griffin, Paul M. and McCarthy, James (2010). Niclosamide. Kucers' the use of antibiotics: a clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs. (pp. 2293-2296) edited by M. Lindsay Grayson, Suzanne M. Crowe, James S. McCarthy, John Mills, Johan W. Mouton, S. Ragnar Norrby, David L. Paterson and Michael A. Pfaller. Boca Raton, FL, United States: CRC Press. doi: 10.1201/b13787-232

Niclosamide

2010

Book Chapter

Furazolidone (furazolidine)

Griffin, Paul M. (2010). Furazolidone (furazolidine). Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic and Antiviral Drugs. (pp. 2114-2120) edited by M. Lindsay Grayson, Suzanne M. Crowe, James S. McCarthy, John Mills, Johan W. Mouton, S. Ragnar Norrby, David L. Paterson and Michael A. Pfaller. Boca Raton, FL, USA: CRC Press. doi: 10.1201/b13787-205

Furazolidone (furazolidine)

2005

Journal Article

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

Dorr, Patrick, Westby, Mike, Dobbs, Susan, Griffin, Paul, Irvine, Becky, Macartney, Malcolm, Mori, Julie, Rickett, Graham, Smith-Burchnell, Caroline, Napier, Carolyn, Webster, Rob, Armour, Duncan, Price, David, Stammen, Blanda, Wood, Anthony and Perros, Manos (2005). Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrobial Agents and Chemotherapy, 49 (11), 4721-4732. doi: 10.1128/AAC.49.11.4721-4732.2005

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

Funding

Past funding

  • 2019 - 2023
    Syphilis in pregnant women and their newborn infants in South-East Queensland 2016-202: A retrospective review of management and outcomes and evaluation of barriers to care
    Children's Health Queensland Hospital and Health Service
    Open grant

Supervision

Availability

Professor Paul Griffin is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

Contact Professor Paul Griffin directly for media enquiries about:

  • COVID-19
  • Infectious Diseases
  • microbiology
  • Vaccines

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au